-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Dovitinib is a synthetic compound that is used in the treatment of various types of cancer.
The development of synthetic routes for this compound has been an active area of research in the chemical industry.
Synthetic routes refer to the various methods that can be used to manufacture a particular compound.
In the case of dovitinib, several synthetic routes have been developed over the years, each with its own advantages and disadvantages.
This article will provide an overview of the synthetic routes of dovitinib and the factors that influence the choice of a particular route.
One of the earliest synthetic routes for dovitinib involved the use of a three-step synthesis starting from a readily available starting material.
This route involved the condensation of a ketone with a Grignard reagent, followed by a dehydration step to form an aldehyde.
The aldehyde was then reduced to form the desired compound.
This route was relatively straightforward and provided a good yield of the final product.
However, it did require the use of several reagents and intermediate steps, which could make it less economical than other synthetic routes.
Another synthetic route for dovitinib involved the use of a modified P2P (Pyrrole-2-propanamine) synthesis route.
This route started with the synthesis of a P2P compound, which was then hydrogenated to form a secondary amine.
This amine was then transformed into the desired compound through a series of chemical reactions, including a Suzuki reaction and a boronic acid reaction.
This route was more complex than the first route, but it was also more efficient, as it only required a single intermediate step to form the desired compound.
This route was also more economical, as it used fewer reagents and intermediates.
A third synthetic route for dovitinib involved the use of an organometallic route.
This route started with the synthesis of a metal complex, which was then treated with a halogen to form an organo-metal intermediate.
This intermediate was then transformed into the desired compound through a series of reactions, including an elimination step and a dehydration step.
This route was more complex than the first two routes, but it was also more efficient, as it provided a high yield of the final product.
However, it did require the use of toxic and expensive reagents, which could make it less practical for large-scale manufacturing.
The choice of synthetic route for dovitinib depends on several factors, including the availability and cost of the starting materials, the yield and purity of the final product, and the scalability and practicality of the route.
In general, routes that require fewer reagents and intermediates are more desirable, as they are more efficient and economical.
However, routes that provide a high yield of the final product are also important, as they allow for the production of a larger quantity of the compound.
In addition, the choice of route may also be influenced by the availability and cost of the starting materials, as some routes require more expensive or harder-to-obtain reagents than others.
Ultimately, the choice of synthetic route for dovitinib will depend on a variety of factors, and the best route will vary depending on the specific requirements of the manufacturing process.